On March 2, 2020 Alligator Bioscience (Nasdaq Stockholm: ATORX), a biotechnology company developing antibody-based pharmaceuticals for tumor-directed immunotherapy, reported that the Swedish version of the Annual Report 2019 is available on the company website www.alligatorbioscience.com (Press release, Alligator Bioscience, MAR 2, 2020, View Source [SID1234555082]). An English version will follow shortly.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The information was submitted for publication, through the agency of the contact person set out above, at 10:30 a.m. CET on 2 March 2020.